Takeyoshi Yamashita
Directeur Technique/Scientifique/R&D chez KYOWA KIRIN CO. LTD.
Profil
Takeyoshi Yamashita currently works at Kyowa Kirin Co., Ltd., as Director & Chief Medical Officer from 2023 and Orchard Therapeutics Plc, as Director from 2024.
Postes actifs de Takeyoshi Yamashita
Sociétés | Poste | Début |
---|---|---|
KYOWA KIRIN CO. LTD. | Directeur Technique/Scientifique/R&D | 01/04/2023 |
ORCHARD THERAPEUTICS PLC | Directeur/Membre du Conseil | 24/01/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
KYOWA KIRIN CO. LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |